Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data — M.A. El Sharouni (2020) | RDL Network
Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data
Article 2020 en
Authors
MS
M.A. El Sharouni
TA
Tasnia Ahmed
AW
Arjen J. Witkamp
Abstract
1 min read
This population-based validation confirmed the value of the EORTC nomogram in predicting recurrence-free survival in patients with SN-negative melanoma. The EORTC nomogram could be used in clinical practice for personalizing follow-up and selecting high-risk patients for trials of adjuvant systemic therapy.
Serigne Lo, Mary‐Ann El Sharouni, Karijn P.M. Suijkerbuijk, Tasnia Ahmed, Witkamp Arjen, Anne Ε. Cust, V. Sigurdsson, P. J. van Diest, Richard A Scolyer, Carla H. van Gils, John F. Thompson
Serigne Lo, Jiawen Ma, Richard A Scolyer, Lauren E. Haydu, Jonathan R. Stretch, Robyn P.M. Saw, Omgo E. Nieweg, Kerwin F. Shannon, Andrew J. Spillane, Sydney Ch’ng, Graham J. Mann, Jeffrey E. Gershenwald, John F. Thompson, Alexander H. R. Varey
Discussion(0)
No comments yet. Be the first to comment.